Social
Media

The AMP® BGTC team will be making a major milestone announcement for their program tomorrow during the first day of the American Society of Gene & Cell Therapy Annual Meeting. Get the news first by signing up for our newsletter: #ASGCT23

FNIH’s Courtney Silverthorn participated in a panel discussion this morning at
@ASGCTherapy discussing accelerated approvals for gene therapies. Learn more about how BGTC is changing the gene therapy paradigm: #ASGCT23

Inequitable access to care failed the world’s response to COVID. The FNIH and
@oneillinstitute brought together global experts to examine how to incorporate health equity models into future pandemic preparedness. Learn more in Health Affairs Forefront:

According to Michael Santos, gene drive is an approach that could introduce a change into a population of mosquitoes to reduce the transmission of malaria. Read more:

Dr. Gerberding will be part of a panel to announce the newly launched Coalition for Trust in Health & Science, an industry-wide coalition of more than 50 healthcare groups aimed to combat persistent problems with health science information. Learn more and register: https://meetings.aaas.org/

FNIH’s Dana Connors, Director of Cancer, Research Partnerships is speaking at CHI’s 30th International Molecular & Precision Med Tri-Con, March 6-8, 2023 in San Diego, on the FNIH Biomarkers Consortium’s MRD projects. Learn more: https://fnih.org/…/biomarkers-consortium-measurable…#PersonalizedMedicine

Linking Alzheimer’s disease with Down syndrome, Dr. Michael Rafii credits the 20-year-old Alzheimer’s Disease Neuroimaging Initiative, or ADNI, managed by the FNIH, which led him to start the Down Syndrome Biomarker Initiative. Read the full story: https://lnkd.in/eD5yGaxw

The FNIH honors the life of Dr. Paul Berg, Nobel Laureate and Emeritus Director of the FNIH. He passed away February 15 at the age of 96, leaving behind a legacy of biomedical breakthroughs for patients. Read more: https://fnih.org/In-memoriam-paul-berg

Advancing #equity is the @WHO pandemic treaty’s goal. @oneillinstitute, @FNIH_Org, and @UNAIDS convened experts in biomedical science, human rights, finance, patient advocacy, and other areas to examine innovative mechanisms: https://fnih.org/what-we-do/programs/consultations-new-international pandemic-agreement #globalhealth #pandmicaccord

FNIH’s AVP of Research Partnerships, Stacey Adam, has been honored as one of IO360’s Women Leadership in Immuno-Oncology 2023. She is appearing at the IO360 Summit and was interviewed for IO360’s newsletter. Read the interview here: https://fnih.org/…/files/2023-02/women_leadership.pdf

The FNIH is pleased to announce the second round of recipients for the Deeda Blair Research Initiative for Disorders of the brain about these physician-scientists who are pursuing research that may transform approaches to mental illness: https://fnih.org/news/announcements/fnih-announces-second-round-awards-deeda-blair-research-initiative-disorders

Launched in April 2022 by the @NIH and managed with oversight by the FNIH, ACTIV achieved rapid testing of potential treatments and mounted the largest, most comprehensive drug repurposing to date. Read More: https://science.org/doi/10.1126/science.adf5167